This inquiry examines the Chief Medical Officer's (Dame Sally Davies) call in her latest annual report, ‘Generation Genome’, for mainstreaming genomic medicine in the NHS within 5 years.
The Committee is now inviting written evidence by 13 October on the Chief Medical Officer’s recommendations, including from those who have already submitted evidence to the previous Committee.
This includes observations on how any barriers to greater integration of genomic therapies in the NHS could be overcome, and how such barriers may differ across the devolved nations.
In doing so, the Committee will take forward the interim report from the previous Committee on Genomics and gene-editing and the evidence it had received before the General Election